Diabetic neuropathy and oxidative stress: Therapeutic perspectives

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Hosseini, Asieh ^a   Abdollahi, Mohammad ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCTS; ALDOSE REDUCTASE INHIBITORS; ANGIOTENSIN-CONVERTING ENZYME; DIABETIC NEUROPATHY; PATHOPHYSIOLOGICAL; PATHWAY INHIBITORS; PERIPHERAL NERVES; PROTEIN KINASE C INHIBITORS;

AMINO ACIDS; ENZYMES; GLYCOSYLATION; PROTEINS;

OXIDATIVE STRESS;

ACETYLCARNITINE; ACETYLSALICYLIC ACID; AMINOGUANIDINE; AMITRIPTYLINE; BENFOTIAMINE; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DULOXETINE; EPALRESTAT; FIDARESTAT; FLUPHENAZINE; GABAPENTIN; HARKOSERIDE; IMIPRAMINE; LAMOTRIGINE; MAPROTILINE; NICOTINAMIDE; NORTRIPTYLINE; OXCARBAZEPINE; PREGABALIN; RANIRESTAT; RUBOXISTAURIN; TAURINE; THIOCTIC ACID; TRANDOLAPRIL; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

BEDTIME DOSAGE; BLOOD GLUCOSE MONITORING; CLINICAL FEATURE; DIABETIC NEUROPATHY; DRUG DOSE TITRATION; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INFLAMMATION; NERVE FIBER; NEUROPATHIC PAIN; NONHUMAN; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DIABETIC NEUROPATHIES; HUMANS; OXIDATIVE STRESS;

EID: 84878293558     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/168039     Document Type: Review

References (116)

1. Peripheral Neuropathy. http://courses.washington.edu/conj/neuron/ peripheralNeuropathy.htm
2. Bril V., Treatments for DN. Journal of the Peripheral Nervous System 2012 2 22 27
3. Callaghan B. C., Cheng H. T., Stables C. L., Smith A. L., Feldman E. L., Diabetic neuropathy: clinical manifestations and current treatments. The Lancet Neurology 2012 11 6 521 534
4. Tesfaye S., Selvarajah D., Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes-Metabolism Research and Reviews 2012 1 8 14
5. Thomas P. K., Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes 1997 46 2 S54 S57 2-s2.0-0030963672 (Pubitemid 27377399)
6. Boulton A. J. M., Vinik A. I., Arezzo J. C., Bril V., Feldman E. L., Freeman R., Malik R. A., Maser R. E., Sosenko J. M., Ziegler D., Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005 28 4 956 962 2-s2.0-20144389536 10.2337/diacare.28.4.956 (Pubitemid 40434506)
7. Tesfaye S., Boulton A. J. M., Dyck P. J., Freeman R., Horowitz M., Kempler P., Lauria G., Malik R. A., Spallone V., Vinik A., Bernardi L., Valensi P., Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010 33 10 2285 2293 2-s2.0-78651101592 10.2337/dc10-1303
8. Negi G., Kumar A., Joshi R. P., Ruby P. K., Sharma S. S., Oxidative stress and diabetic neuropathy: current status of antioxidants. Institute of Integrative Omics and Applied Biotechnology 2011 2 6 71 78
9. Edwards J. L., Vincent A. M., Cheng H. T., Feldman E. L., Diabetic neuropathy: mechanisms to management. Pharmacology & Therapeutics 2008 120 1 1 34 2-s2.0-51749110211 10.1016/j.pharmthera.2008.05.005
10. Mahmood D., Singh B. K., Akhtar M., Diabetic neuropathy: therapies on the horizon. Journal of Pharmacy and Pharmacology 2009 61 9 1137 1145 2-s2.0-70350501530 10.1211/jpp/61.09.0002
11. Rajbhandari S. M., Piya M. K., A brief review on the pathogenesis of human diabetic neuropathy: observations and postulations. International Journal of Diabetes and Metabolism 2005 13 3 135 140 2-s2.0-33751226252 (Pubitemid 44783784)
12. Yagihashi S., Mizukami H., Sugimoto K., Mechanism of diabetic neuropathy: where are we now and where to go? Journal of Diabetes Investigation 2011 2 1 18 32 2-s2.0-79960525595 10.1111/j.2040-1124.2010.00070.x
13. Head K. A., Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Alternative Medicine Review 2006 11 4 294 329 2-s2.0-33845927528 (Pubitemid 46037130)
14. Shakher J., Stevens M. J., Update on the management of diabetic polyneuropathies. Diabetes, Metabolic Syndrome and Obesity 2011 4 289 305
15. Max M. B., Endogenous monoamine analgesic systems: amitriptyline in painful diabetic neuropathy. Anesthesia Progress 1987 34 4 123 127 2-s2.0-0023232192 (Pubitemid 17147404)
16. Max M. B., Culnane M., Schafer S. C., Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987 37 4 589 596 2-s2.0-0023155057 (Pubitemid 17057933)
17. Max M. B., Lynch S. A., Muir J., Shoaf S. E., Smoller B., Dubner R., Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. The New England Journal of Medicine 1992 326 19 1250 1256 2-s2.0-0026522154
18. Vrethem M., Boivie J., Arnqvist H., Holmgren H., Lindström T., Thorell L. H., A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clinical Journal of Pain 1997 13 4 313 323 2-s2.0-0031441947 10.1097/00002508-199712000-00009 (Pubitemid 28028096)
19. Morello C. M., Leckband S. G., Stoner C. P., Moorhouse D. F., Sahagian G. A., Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Archives of Internal Medicine 1999 159 16 1931 1937 2-s2.0-0033552134 10.1001/archinte.159.16.1931 (Pubitemid 29424714)
20. Sindrup S. H., Gram L. F., Skjold T., Grodum E., Brøsen K., Beck-Nielsen H., Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. British Journal of Clinical Pharmacology 1990 30 5 683 691 2-s2.0-0025011753 (Pubitemid 20377596)
21. Max M. B., Kishore-Kumar R., Schafer S. C., Meister B., Gracely R. H., Smoller B., Dubner R., Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 1991 45 1 3 9 2-s2.0-0025754758 10.1016/0304-3959(91)90157-S
22. Kvinesdal B., Molin J., Frøland A., Gram L. F., Imipramine treatment of painful diabetic neuropathy. Journal of the American Medical Association 1984 251 13 1727 1730 2-s2.0-0021328357 10.1001/jama.251.13.1727 (Pubitemid 14174179)
23. Gomez-Perez F. J., Rull J. A., Dies H., Rodriquez-Rivera J. G., Gonzalez-Barranco J., Lozano-Castañeda O., Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study. Pain 1985 23 4 395 400 2-s2.0-0022352168 (Pubitemid 16212853)
24. Sindrup S. H., Bjerre U., Dejgaard A., Brøsen K., Aaes-Jørgensen T., Gram L. F., The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clinical Pharmacology and Therapeutics 1992 52 5 547 552 2-s2.0-0026445809
25. Simpson D. A., Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. Journal of Clinical Neuromuscular Disease 2001 3 2 53 62 2-s2.0-0035204953 (Pubitemid 33130299)
26. Sindrup S. H., Bach F. W., Madsen C., Gram L. F., Jensen T. S., Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003 60 8 1284 1289 2-s2.0-0347185884 (Pubitemid 36460983)
27. Rowbotham M. C., Goli V., Kunz N. R., Lei D., Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004 110 3 697 706 2-s2.0-3843053823 10.1016/j.pain.2004.05.010 (Pubitemid 39036802)
28. Kadiroglu A. K., Sit D., Kayabasi H., Kemal Tuzcu A., Tasdemir N., Yilmaz M. E., The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications 2008 22 4 241 245 2-s2.0-45849106140 10.1016/j.jdiacomp.2007.03. 010 (Pubitemid 351885487)
29. Raskin J., Pritchett Y. L., Wang F., D'Souza D. N., Waninger A. L., Iyengar S., Wernicke J. F., A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Medicine 2005 6 5 346 356 2-s2.0-28444459170 10.1111/j.1526-4637.2005.00061.x (Pubitemid 41727332)
30. Goldstein D. J., Lu Y., Detke M. J., Lee T. C., Iyengar S., Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005 116 1-2 109 118 2-s2.0-20444464304 10.1016/j.pain.2005.03.029 (Pubitemid 40828506)
31. Wernicke J. F., Pritchett Y. L., D'Souza D. N., Waninger A., Tran P., Iyengar S., Raskin J., A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006 67 8 1411 1420 2-s2.0-33750341692 10.1212/01.wnl.0000240225.04000.1a (Pubitemid 44632065)
32. Kajdasz D. K., Iyengar S., Desaiah D., Backonja M. M., Farrar J. T., Fishbain D. A., Jensen T. S., Rowbotham M. C., Sang C. N., Ziegler D., McQuay H. J., Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. Clinical Therapeutics 2007 29 11 2536 2546 2-s2.0-37349086775 10.1016/j.clinthera.2007.12.002 (Pubitemid 350299457)
33. Lesser H., Sharma U., LaMoreaux L., Poole R. M., Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004 63 11 2104 2110 2-s2.0-10444245040 (Pubitemid 39636259)
34. Rosenstock J., Tuchman M., Lamoreaux L., Sharma U., Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004 110 3 628 638 2-s2.0-3843088696 10.1016/j.pain.2004.05.001 (Pubitemid 39036794)
35. Richter R. W., Portenoy R., Sharma U., Lamoreaux L., Bockbrader H., Knapp L. E., Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. Journal of Pain 2005 6 4 253 260 2-s2.0-16844380945 10.1016/j.jpain.2004.12.007 (Pubitemid 40488803)
36. Freynhagen R., Strojek K., Griesing T., Whalen E., Balkenohl M., Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005 115 3 254 263 2-s2.0-19444362218 10.1016/j.pain.2005.02.032 (Pubitemid 40725282)
37. Tölle T., Freynhagen R., Versavel M., Trostmann U., Young J. P. Jr., Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. European Journal of Pain 2008 12 2 203 213 2-s2.0-36549031246 10.1016/j.ejpain.2007.05.003 (Pubitemid 350180540)
38. Arezzo J. C., Rosenstock J., LaMoreaux L., Pauer L., Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurology 2008 8, article 33 2-s2.0-53949084617 10.1186/1471-2377-8-33
39. Freeman R., Durso-DeCruz E., Emir B., Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care 2008 31 7 1448 1454 2-s2.0-45849095237 10.2337/dc07-2105
40. Backonja M., Beydoun A., Edwards K. R., Schwartz S. L., Fonseca V., Hes M., LaMoreaux L., Garofalo E., Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. A randomized controlled trial. Journal of the American Medical Association 1998 280 21 1831 1836 2-s2.0-0032477294 (Pubitemid 28544423)
41. Gorson K. C., Schott C., Herman R., Ropper A. H., Rand W. M., Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. Journal of Neurology Neurosurgery and Psychiatry 1999 66 2 251 252 2-s2.0-0032910201 (Pubitemid 29103537)
42. Kochar D. K., Jain N., Agarwal R. P., Srivastava T., Agarwal P., Gupta S., Sodium valproate in the management of painful neuropathy in type 2 diabetes-a randomized placebo controlled study. Acta Neurologica Scandinavica 2002 106 5 248 252 2-s2.0-0036838156 10.1034/j.1600-0404.2002.01229.x (Pubitemid 35177990)
43. Kochar D. K., Rawat N., Agrawal R. P., Vyas A., Beniwal R., Kochar S. K., Garg P., Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM 2004 97 1 33 38 2-s2.0-1042269461 10.1093/qjmed/hch007 (Pubitemid 38195700)
44. Otto M., Bach F. W., Jensen T. S., Sindrup S. H., Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial. Neurology 2004 62 2 285 288 2-s2.0-0842325640 (Pubitemid 38167141)
45. Eisenberg E., Lurie Y., Braker C., Daoud D., Ishay A., Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001 57 3 505 509 2-s2.0-0035859943 (Pubitemid 32757601)
46. Vinik A. I., Tuchman M., Safirstein B., Corder C., Kirby L., Wilks K., Quessy S., Blum D., Grainger J., White J., Silver M., Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain 2007 128 1-2 169 179 2-s2.0-33846822012 10.1016/j.pain.2006.09.040 (Pubitemid 46216610)
47. Jose V. M., Bhansali A., Hota D., Pandhi P., Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabetic Medicine 2007 24 4 377 383 2-s2.0-33947411319 10.1111/j.1464-5491.2007.02093.x (Pubitemid 46452398)
48. Rull J. A., Quibrera R., González-Millán H., Castañeda O. L., Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 1969 5 4 215 218 2-s2.0-0014551722 10.1007/BF01212087
49. Dogra S., Beydoun S., Mazzola J., Hopwood M., Wan Y., Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. European Journal of Pain 2005 9 5 543 554 2-s2.0-24044458603 10.1016/j.ejpain.2004.11.006 (Pubitemid 41219786)
50. Beydoun A., Shaibani A., Hopwood M., Wan Y., Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurologica Scandinavica 2006 113 6 395 404 2-s2.0-33745911608 10.1111/j.1600-0404.2006. 00631.x (Pubitemid 44046325)
51. Grosskopf J., Mazzola J., Wan Y., Hopwood M., A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy. Acta Neurologica Scandinavica 2006 114 3 177 180 2-s2.0-33746866695 10.1111/j.1600-0404.2005.00559.x (Pubitemid 44185910)
52. Rauck R. L., Shaibani A., Biton V., Simpson J., Koch B., Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clinical Journal of Pain 2007 23 2 150 158 2-s2.0-33846535387 10.1097/01.ajp.0000210957.39621.b2 (Pubitemid 46150939)
53. Wymer J. P., Simpson J., Sen D., Bongardt S., Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clinical Journal of Pain 2009 25 5 376 385 2-s2.0-67649391445 10.1097/AJP.0b013e318196d2b6
54. Harati Y., Gooch C., Swenson M., Edelman S., Greene D., Raskin P., Donofrio P., Cornblath D., Sachdeo R., Siu C. O., Kamin M., Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998 50 6 1842 1846 2-s2.0-0031779616 (Pubitemid 28283262)
55. Sindrup S. H., Andersen G., Madsen C., Smith T., Brøsen K., Jensen T. S., Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 1999 83 1 85 90 2-s2.0-0032877110 10.1016/S0304-3959(99)00079-2 (Pubitemid 29446160)
56. Freeman R., Raskin P., Hewitt D. J., Vorsanger G. J., Jordan D. M., Xiang J., Rosenthal N. R., Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy. Current Medical Research and Opinion 2007 23 1 147 161 2-s2.0-33846698387 10.1185/030079906X162674 (Pubitemid 46191680)
57. Gimbel J. S., Richards P., Portenoy R. K., Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003 60 6 927 934 2-s2.0-0037465723 (Pubitemid 36348923)
58. Watson C. P. N., Moulin D., Watt-Watson J., Gordon A., Eisenhoffer J., Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003 105 1-2 71 78 2-s2.0-0141738781 10.1016/S0304-3959(03)00160-X (Pubitemid 37162475)
59. Hanna M., O'Brien C., Wilson M. C., Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. European Journal of Pain 2008 12 6 804 813 2-s2.0-44649189147 10.1016/j.ejpain.2007.12.010
60. Gilron I., Bailey J. M., Tu D., Holden R. R., Weaver D. F., Houlden R. L., Morphine, gabapentin, or their combination for neuropathic pain. The New England Journal of Medicine 2005 352 13 1324 1334 2-s2.0-15744389846 10.1056/NEJMoa042580 (Pubitemid 40411499)
61. Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group. Archives of Internal Medicine 1991 151 11 2225 2229 2-s2.0-0025841729 10.1001/archinte.151.11.2225
62. Scheffler N. M., Sheitel P. L., Lipton M. N., Treatment of painful diabetic neuropathy with capsaicin 0.075%. Journal of the American Podiatric Medical Association 1991 81 6 288 293 2-s2.0-0026177226
63. Tandan R., Lewis G. A., Krusinski P. B., Badger G. B., Fries T. J., Topical capsaicin in painful diabetic neuropathy. Diabetes Care 1992 15 1 8 14 2-s2.0-0026500908
64. Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Capsaicin Study Group. Diabetes Care 1992 15 2 159 165 2-s2.0-11944264672
65. Yuen K. C. J., Baker N. R., Rayman G., Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diabetes Care 2002 25 10 1699 1703 2-s2.0-0036781580 10.2337/diacare.25.10.1699 (Pubitemid 41071073)
66. Agrawal R. P., Choudhary R., Sharma P., Sharma S., Beniwal R., Kaswan K., Kochar D. K., Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double blind placebo controlled cross-over study. Diabetes Research and Clinical Practice 2007 77 2 161 167 2-s2.0-34247615434 10.1016/j.diabres.2006.12.003 (Pubitemid 46670414)
67. Meier T., Wasner G., Faust M., Kuntzer T., Ochsner F., Hueppe M., Bogousslavsky J., Baron R., Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003 106 1-2 151 158 2-s2.0-0142196073 10.1016/S0304-3959(03)00317-8 (Pubitemid 37329625)
68. Barbano R. L., Herrmann D. N., Hart-Gouleau S., Pennella-Vaughan J., Lodewick P. A., Dworkin R. H., Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Archives of Neurology 2004 61 6 914 918 2-s2.0-2942532905 10.1001/archneur.61.6.914 (Pubitemid 38747332)
69. Dejgard A., Kastrup J., Petersen P., Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1988 1 8575-8576 9 11 2-s2.0-0023838493 (Pubitemid 18017201)
70. Oskarsson P., Ljunggren J. G., Lins P. E., Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. Diabetes Care 1997 20 10 1594 1597 2-s2.0-0030798224 (Pubitemid 27415040)
71. Wright J. M., Oki J. C., Graves L., Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy. Annals of Pharmacotherapy 1997 31 1 29 34 2-s2.0-0031026167 (Pubitemid 27030061)
72. Nelson K. A., Park K. M., Robinovitz E., Tsigos C., Max M. B., High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997 48 5 1212 1218 2-s2.0-0030992921 (Pubitemid 27240536)
73. Sang C. N., Booher S., Gilron I., Parada S., Max M. B., Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 2002 96 5 1053 1061 2-s2.0-0036235004 10.1097/00000542-200205000-00005 (Pubitemid 34462564)
74. Ranoux D., Attal N., Morain F., Bouhassira D., Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Annals of Neurology 2008 64 3 274 283 2-s2.0-54849435847 10.1002/ana.21427
75. Yuan R. Y., Sheu J. J., Yu J. M., Chen W. T., Tseng I. J., Chang H. H., Hu C. J., Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology 2009 72 17 1473 1478 2-s2.0-67549127798 10.1212/01.wnl.0000345968.05959.cf
76. Sima A. A. F., Calvani M., Mehra M., Amato A., Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care 2005 28 1 89 94 2-s2.0-11844273799 10.2337/diacare.28.1.89 (Pubitemid 40095788)
77. Ziegler D., Hanefeld M., Ruhnau K. J., Hasche H., Lobisch M., Schütte K., Kerum G., Malessa R., Treatment of symptomatic diabetic polyneuropathy with the antioxidant α -lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999 22 8 1296 1301 2-s2.0-0032788081 10.2337/diacare.22.8.1296 (Pubitemid 29350240)
78. Ziegler D., Nowak H., Kempler P., Vargha P., Low P. A., Treatment of symptomatic diabetic polyneuropathy with the antioxidant α -lipoic acid: a meta-analysis. Diabetic Medicine 2004 21 2 114 121 2-s2.0-1242337352 10.1111/j.1464-5491.2004.01109.x (Pubitemid 38221809)
79. Yu X., Zhang L., Yang X., Salvianolic acid A protects the peripheral nerve function in diabetic rats through regulation of the AMPK-PGC1 α -Sirt3 axis. Molecules 2012 17 9 11216 11228
80. Coppey L. J., Holmes A., Davidson E. P., Yorek M. A., Partial replacement with menhaden oil improves peripheral neuropathy in high-fat-fed low-dose streptozotocin type 2 diabetic rat. Journal of Nutrition and Metabolism 2012 2012 8 10.1155/2012/950517 950517
81. Ahn S., Song R., Effects of Tai Chi Exercise on glucose control, neuropathy scores, balance, and quality of life in patients with type 2 diabetes and neuropathy. Journal of Alternative and Complementary Medicine 2012 18 12 1172 1178 10.1089/acm.2011.0690
82. Shin S., Kim K. J., Chang H. J., The effect of oral prostaglandin analogue on painful diabetic neuropathy: a double-blind, randomized, controlled trial. Diabetes, Obesity and Metabolism 2012 15 2 185 188 10.1111/dom.12010
83. Schreiber A. K., Neufeld M., Jesus C. H., Cunha J. M., Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats. Neuropharmacology 2012 63 8 1286 1297
84. Wang L., Chopp M., Szalad A., Thymosin β 4 promotes the recovery of peripheral neuropathy in type II diabetic mice. Neurobiology of Disease 2012 48 3 546 555 10.1016/j.nbd.2012.08.002
85. Sun W., Miao B., Wang X. C., Gastrodin inhibits allodynia and hyperalgesia in painful DN rats by decreasing excitability of nociceptive primary sensory neurons. PLoS ONE 2012 7 6 e39647
86. Hotta N., Kawamori R., Fukuda M., Shigeta Y., Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy. Diabetic Medicine 2012 29 12 1529 1533
87. Attia H. N., Al-Rasheed N. M., Al-Rasheed N. M., Maklad Y. A., Ahmed A. A., Kenawy S. A., Protective effects of combined therapy of gliclazide with curcumin in experimental DN in rats. Behavioural Pharmacology 2012 23 2 153 161
88. Naruse K., Sato J., Funakubo M., Transplantation of bone marrow-derived mononuclear cells improves mechanical hyperalgesia, cold allodynia and nerve function in DN. PLoS ONE 2011 6 11 e27458
89. Xu X., Jiang Liu H., Zhang W., Xu X., Li Z., The effects of galanin on dorsal root ganglion neurons with high glucose treatment in vitro. Brain Research Bulletin 2012 87 1 85 93
90. Yorek M. A., Treatment of DN with baicalein: intervention at multiple sites. Experimental Neurology 2011 232 2 105 109
91. Dalmolin G. D., Silva C. R., Rigo F. K., Antinociceptive effect of Brazilian armed spider venom toxin Tx3-3 in animal models of neuropathic pain. Pain 2011 152 10 2224 2232 10.1016/j.pain.2011.04.015
92. Hosseini A., Sharifzadeh M., Rezayat S. M., Hassanzadeh G., Hassani S., Baeeri M., Shetab-Bushehri V., Kuznetsov D. A., Abdollahi M., Benefit of magnesium-25 carrying porphyrin-fullerene nanoparticles in experimental diabetic neuropathy. International Journal of Nanomedicine 2010 5 1 517 523 2-s2.0-77958522543
93. Hosseini A., Abdollahi M., Hassanzadeh G., Protective effect of magnesium-25 carrying porphyrin-fullerene nanoparticles on degeneration of dorsal root ganglion neurons and motor function in experimental DN. Basic & Clinical Pharmacology & Toxicology 2011 109 5 381 386 10.1111/j.1742-7843. 2011.00741.x
94. Milani E., Nikfar S., Khorasani R., Zamani M. J., Abdollahi M., Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Comparative Biochemistry and Physiology Part C 2005 140 2 251 255 2-s2.0-19344375531 10.1016/j.cca.2005.02.010 (Pubitemid 40720044)
95. Larijani B., Salimi M., Pourkhalili N., Positive response of isolated rat pancreatic islets to IMOD; hopes for better transplant outcome and graft function. Asian Journal of Animal and Veterinary Advances 2011 6 10 1019 1025 10.3923/ajava.2011.1019.1025
96. Hosseini A., Abdollahi M., It is time to formulate an antioxidant mixture for management of diabetes and its complications: notice for phannaceutical industries. International Journal of Pharmacology 2012 8 1 60 61
97. Hosseini A., Abdollahi M., Through a mechanism-based approach, nanoparticles of cerium and yttrium may improve the outcome of pancreatic islet isolation. Journal of Medical Hypotheses and Ideas 2012 6 4 6
98. Jensen T. S., Backonja M. M., Hernández Jiménez S., Tesfaye S., Valensi P., Ziegler D., New perspectives on the management of diabetic peripheral neuropathic pain. Diabetes and Vascular Disease Research 2006 3 2 108 119 2-s2.0-33750396100 10.3132/dvdr.2006.013 (Pubitemid 44638385)
99. Lindsay T. J., Rodgers B. C., Savath V., Hettinger K., Treating diabetic peripheral neuropathic pain. American Family Physician 2010 82 2 151 158 2-s2.0-77955494873
100. Finnerup N. B., Otto M., McQuay H. J., Jensen T. S., Sindrup S. H., Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005 118 3 289 305 2-s2.0-27944467013 10.1016/j.pain.2005.08.013 (Pubitemid 41752987)
101. Ziegler D., Painful diabetic neuropathy: advantage of novel drugs over old drugs? Diabetes care 2009 32 S414 419 2-s2.0-75549084221
102. Sultan A., Gaskell H., Derry S., Andrew R. A., Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurology 2008 8, article 29 2-s2.0-51349119038 10.1186/1471-2377-8- 29
103. Devitt M., AAN, AANEM, and AAPMR publish guideline for treatment of painful diabetic neuropath. American Family Physician 2012 86 5 469 470
104. Seidel S., Aigner M., Ossege M., Pernicka E., Wildner B., Sycha T., Antipsychotics for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2008 4 CD004844 2-s2.0-58249085098
105. Lindsay T. J., vitrikas K., Temporal M., Herndon C. M., Diabetic neuropathic pain: real world treatment options. Clinical Medicine Insights: Therapeutics 2012 4 169 183
106. Vinik A. I., Bril V., Kempler P., Litchy W. J., Tesfaye S., Price K. L., Bastyr E. J., Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β -inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clinical Therapeutics 2005 27 8 1164 1180 2-s2.0-25844459952 10.1016/j.clinthera.2005.08. 001 (Pubitemid 41393912)
107. Hotta N., Toyota T., Matsuoka K., Shigeta Y., Kikkawa R., Kaneko T., Takahashi A., Sugimura K., Koike Y., Ishii J., Sakamoto N., Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care 2001 24 10 1776 1782 2-s2.0-0035486938 (Pubitemid 33716481)
108. Hotta N., Akanuma Y., Kawamori R., Matsuoka K., Oka Y., Shichiri M., Toyota T., Nakashima M., Yoshimura I., Sakamoto N., Shigeta Y., Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complications trial. Diabetes Care 2006 29 7 1538 1544 2-s2.0-33746456027 10.2337/dc05-2370 (Pubitemid 44127578)
109. Bril V., Hirose T., Tomioka S., Buchanan R., Ranirestat for the management of diabetic sensorimotor polyneuropathy. Diabetes Care 2009 32 7 1256 1260 2-s2.0-67650076664 10.2337/dc08-2110
110. Haupt E., Ledermann H., Köpcke W., Benfotiamine in the treatment of diabetic polyneuropathy-a three-week randomized, controlled pilot study (BEDIP study). International Journal of Clinical Pharmacology and Therapeutics 2005 43 2 71 77 2-s2.0-14544300095 (Pubitemid 40298057)
111. Rahimi R., Nikfar S., Larijani B., Abdollahi M., A review on the role of antioxidants in the management of diabetes and its complications. Biomedicine and Pharmacotherapy 2005 59 7 365 373 2-s2.0-24044513942 10.1016/j.biopha.2005. 07.002 (Pubitemid 41219650)
112. Monfared S. S. M. S., Larijani B., Abdollahi M., Islet transplantation and antioxidant management: a comprehensive review. World Journal of Gastroenterology 2009 15 10 1153 1161 2-s2.0-65649119589 10.3748/wjg.15.1153
113. Hasani-Ranjbar S., Larijani B., Abdollah M., A systematic review of iranian medicinal plants useful in diabetes mellitus. Archives of Medical Science 2008 4 3 285 292 2-s2.0-58549120014
114. Tabatabaei-Malazy O., Larijani B., Abdollahi M., A systematic review of in vitro studies conducted on effect of herbal products on secretion of insulin from Langerhans islets. Journal of Pharmacy & Pharmaceutical Sciences 2012 15 3 447 466
115. Momtaz S., Abdollahi M., An update on pharmacology of Satureja species; from antioxidant, antimicrobial, antidiabetes and anti-hyperlipidemic to reproductive stimulation. International Journal of Pharmacology 2010 6 4 454 461 2-s2.0-77955649334
116. Mehri A., Hasani-Ranjbar S., Larijani B., Abdollahi M., A systematic review of efficacy and safety of urtica dioica in the treatment of diabetes. International Journal of Pharmacology 2011 7 2 161 170 2-s2.0-79957843164 10.3923/ijp.2011.161.170